Literature DB >> 24894401

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

Renu A Kowluru1, Julia M Santos1, Qing Zhong1.   

Abstract

PURPOSE: In the pathogenesis of diabetic retinopathy, matrix metalloproteinase (MMP)-9 damages retinal mitochondria, activating the apoptotic machinery. Transcription of MMP-9 is regulated by nuclear factor kappa B (NF-κB), and the activation of NF-κB is modulated by the acetylation of its p65 subunit. Sirtuin 1 (Sirt1), a deacetylase, plays an important role in the acetylation-deacetylation of p65. The goal of this study is to investigate the role of Sirt1 in the activation of MMP-9 in diabetic retinopathy.
METHODS: The effect of hyperglycemia and Sirt1 activator, resveratrol, on acetylation of p65 and its binding at MMP-9 promoter-and mitochondrial damage and apoptosis-was assessed in the retinal endothelial cells. Role of oxidative stress in the regulation of Sirt1 was evaluated in the cells incubated in H2O2. The results were confirmed in the retina from diabetic mice with Sod2 or MMP-9 gene manipulated.
RESULTS: High glucose decreased Sirt1 activity and increased p65 acetylation, and resveratrol prevented increase in p65 acetylation, binding of p65 at MMP-9 promoter and MMP-9 activation, mitochondria damage, and cell apoptosis. While Sirt1 was decreased by H2O2, MMP-9 was significantly increased. Retina from wild-type diabetic mice presented similar decrease in Sirt1, and diabetic mice with Sod2 overexpression or MMP-9 deletion had normal retinal Sirt1. Retinal microvasculature from human donors with established diabetic retinopathy also had decreased Sirt1.
CONCLUSIONS: Thus, in diabetes, increase in oxidative stress inhibits Sirt1 and p65 is hyperacetylated, increasing the binding of p65 at MMP-9 promoter. Prevention of Sirt1 inhibition, via modulating acetylation of p65, should protect activation of MMP-9 and inhibit the development of diabetic retinopathy. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  MMP-9; NF-kB; Sirt1; diabetic retinopathy; posttranslational modification

Mesh:

Substances:

Year:  2014        PMID: 24894401      PMCID: PMC4160094          DOI: 10.1167/iovs.14-14383

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  55 in total

Review 1.  The role of SirT1 in muscle mitochondrial turnover.

Authors:  Keir J Menzies; David A Hood
Journal:  Mitochondrion       Date:  2011-03-23       Impact factor: 4.160

Review 2.  Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation.

Authors:  Jiujiu Yu; Johan Auwerx
Journal:  Pharmacol Res       Date:  2009-12-21       Impact factor: 7.658

3.  Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

4.  Damaged mitochondrial DNA replication system and the development of diabetic retinopathy.

Authors:  Shikha Tewari; Julia M Santos; Renu A Kowluru
Journal:  Antioxid Redox Signal       Date:  2012-02-17       Impact factor: 8.401

5.  Oxidative stress, thiol redox signaling methods in epigenetics.

Authors:  Isaac K Sundar; Samuel Caito; Hongwei Yao; Irfan Rahman
Journal:  Methods Enzymol       Date:  2010-06-20       Impact factor: 1.600

Review 6.  Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.

Authors:  Renu A Kowluru; Qing Zhong; Julia M Santos
Journal:  Expert Opin Investig Drugs       Date:  2012-04-23       Impact factor: 6.206

7.  Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.

Authors:  I Robert; M Aussems; A Keutgens; X Zhang; B Hennuy; P Viatour; G Vanstraelen; M-P Merville; J-P Chapelle; L de Leval; F Lambert; E Dejardin; A Gothot; A Chariot
Journal:  Oncogene       Date:  2009-02-16       Impact factor: 9.867

8.  Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence.

Authors:  Houzao Chen; Yanzhen Wan; Shuang Zhou; Yunbiao Lu; Zhuqin Zhang; Ran Zhang; Feng Chen; Delong Hao; Xiang Zhao; Zhichen Guo; Depei Liu; Chihchuan Liang
Journal:  Sci China Life Sci       Date:  2012-06-29       Impact factor: 6.038

9.  Sirt1 involvement in rd10 mouse retinal degeneration.

Authors:  Carolina Jaliffa; Ilhame Ameqrane; Anouk Dansault; Julia Leemput; Véronique Vieira; Emmanuelle Lacassagne; Alexandra Provost; Karine Bigot; Christel Masson; Maurice Menasche; Marc Abitbol
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

10.  Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB.

Authors:  Xiao-Dong Yang; Emad Tajkhorshid; Lin-Feng Chen
Journal:  Mol Cell Biol       Date:  2010-02-16       Impact factor: 4.272

View more
  47 in total

1.  Sirt1: A Guardian of the Development of Diabetic Retinopathy.

Authors:  Manish Mishra; Arul J Duraisamy; Renu A Kowluru
Journal:  Diabetes       Date:  2018-01-08       Impact factor: 9.461

2.  Diabetic retinopathy and transcriptional regulation of a small molecular weight G-Protein, Rac1.

Authors:  Renu A Kowluru; Manish Mishra; Binit Kumar
Journal:  Exp Eye Res       Date:  2016-04-22       Impact factor: 3.467

Review 3.  Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.

Authors:  Renu A Kowluru; Manish Mishra
Journal:  Free Radic Biol Med       Date:  2016-12-22       Impact factor: 7.376

4.  Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.

Authors:  Manish Mishra; Renu A Kowluru
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-03       Impact factor: 5.187

Review 5.  Mitochondrial pathways to cardiac recovery: TFAM.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

6.  Recombinant human maspin inhibits high glucose-induced oxidative stress and angiogenesis of human retinal microvascular endothelial cells via PI3K/AKT pathway.

Authors:  Feng Qiu; Huijuan Tong; Yawen Wang; Jun Tao; Hailin Wang; Lei Chen
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

Review 7.  Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.

Authors:  Renu A Kowluru; Manish Mishra
Journal:  Expert Opin Ther Targets       Date:  2018-03       Impact factor: 6.902

Review 8.  Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

Authors:  Levi W Evans; Matthew S Stratton; Bradley S Ferguson
Journal:  Nat Prod Rep       Date:  2020-01-29       Impact factor: 13.423

Review 9.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

Review 10.  NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies.

Authors:  Jonathan B Lin; Rajendra S Apte
Journal:  Prog Retin Eye Res       Date:  2018-06-12       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.